Impedance Plethysmography Based Deep Vein Thrombosis Monitoring During Catheter-directed Thrombolysis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTampere University

About this trial

The purpose of this study is to collect data on blood circulation using a multi-frequency impedance plethysmography device developed in the ThrombUS+ project. Impedance plethysmography (IPG) is a non-invasive method that measures changes in blood volume using electrodes placed on the skin. The collected data will be used for device development, the improvement of diagnostic data analysis methods, and AI training.

A total of 40 participants will be recruited for this study, with 20 healthy volunteers in Tampere University and 20 patients undergoing thrombolytic therapy for DVT at Tampere University Hospital.

Eligibility criteria

Qualifiers

Age: 18 or older;

DVT detected on other lower limb;

Suitable for CDT treatment;

Ability to give informed consent;

Disqualifiers

Age under 18 years;

Inability to give informed consent;

Denial;

Too injured skin in the measurement area

Trial design

Treatments tested in this trial

  • Impedance plethysmography IPG
  • Venous Occlusion Plethysmography VOP
  • Breathing and leg movement exercise

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Tampere University

Lead sponsor

Tampere University Hospital

Collaborator